Flu vaccination coverage among US healthcare personnel reached 83% in 2019-2020. A mandate can push that rate above 96%, revealing a clear gap between professional knowledge and public action. This data shows who gets protected and who remains vulnerable each season.
Key Takeaways
- Flu vaccination coverage among healthcare personnel reached 83% in 2019-2020 US
- US adult flu vaccination rate 52.9% for 2022-2023 season, per NHIS survey
- Children 6m-17y flu vac coverage 57.9% in 2022-2023, CDC data
- In the 2022-2023 influenza season, the flu vaccine effectiveness against hospitalization was estimated at 46% overall for adults aged 18 years and older in the United States
- The 2021-2022 flu vaccine was 35% effective in preventing influenza-associated outpatient visits among children aged 6 months to 17 years, based on CDC surveillance data
- Flu vaccination reduced the risk of influenza-related hospitalization by 40% in pregnant women during the 2019-2020 season, per CDC analysis
- Flu vaccination prevented an estimated 7.5 million illnesses, 3.5 million medical visits, 100,000 hospitalizations, and 7,000 deaths in 2022-2023 US season
- From 2010-2020, flu vaccines prevented 13 million illnesses and 110,000 deaths in US
- Flu shots averted 4.4 million cases and saved $1.2 billion healthcare costs in 2019-2020 US
- Flu vac recommended annually for everyone 6 months and older by CDC ACIP
- High-dose or adjuvanted vaccines preferred for 65+ adults per 2022 ACIP
- Pregnant women should receive inactivated flu vaccine any trimester, WHO/ACIP
- Only 1.4% of people reported severe allergic reactions to flu shots from 2010-2020 VAERS data
- Guillain-Barré Syndrome risk after flu vaccine is about 1-2 additional cases per million doses, lower than flu illness risk
- No increased risk of miscarriage from flu vaccine in first trimester, per 2021 meta-analysis of 2 million pregnancies
Flu shots protect more people than ever, yet global coverage still lags far below targets.
Related reading
01 · Category
Coverage26 stats
01
Flu vaccination coverage among healthcare personnel reached 83% in 2019-2020 US
02
US adult flu vaccination rate 52.9% for 2022-2023 season, per NHIS survey
03
Children 6m-17y flu vac coverage 57.9% in 2022-2023, CDC data
04
Pregnant women US flu vac rate 49.3% in 2021-2022
05
Seniors 65+ coverage 74.2% in 2022-2023, highest group
06
Global flu vac coverage <10% in low-income countries 2022 WHO estimate
07
US HCP vac rate 91.7% in 2022-2023
08
School-aged children coverage increased 5% from 2019 to 2023
09
Medicaid enrollees flu vac 47% in 2021-2022
10
Rural US adults flu vac 45.2% vs 54.1% urban 2022
11
Hispanic adults coverage 43.1% in 2022-2023, lower than non-Hispanic white 56.2%
12
Employer-mandated vac led to 96% HCP coverage in hospitals 2020
13
WHO target 75% seniors coverage by 2030, current EU avg 47%
14
US college students flu vac 41.3% in 2022 NIS
15
Black non-Hispanic adults 44.4% coverage 2022-2023
16
Asia-Pacific flu vac coverage avg 25% in 2022
17
Nursing home residents 85% vaccinated 2022 CMS data
18
Teachers coverage 48% in US schools 2022
19
Low-income countries <5% pregnant women vaccinated 2023 GAVI report
20
US veterans 72% flu vac rate 2022 VA data
21
First Nations Canada flu vac 52% vs 38% general pop 2022
22
Pharmacist-administered shots boosted coverage by 10% in 2019 study
23
UK flu vac uptake 75.3% over-65s 2022-2023
24
Australia 2022 flu vac coverage 35% adults
25
US 6m-4y children coverage 64.6% 2022-2023
26
Global pediatric coverage <20% outside high-income countries 2023
Interpretation
Coverage Interpretation
The data reveals a stark and somewhat predictable hierarchy of flu shot adoption: healthcare workers, who see the consequences firsthand, lead the charge at over 90%, while the general adult population lingers around a coin-flip's chance of 53%, proving that nothing motivates like professional proximity to suffering.
02 · Category
Efficacy30 stats
01
In the 2022-2023 influenza season, the flu vaccine effectiveness against hospitalization was estimated at 46% overall for adults aged 18 years and older in the United States
02
The 2021-2022 flu vaccine was 35% effective in preventing influenza-associated outpatient visits among children aged 6 months to 17 years, based on CDC surveillance data
03
Flu vaccination reduced the risk of influenza-related hospitalization by 40% in pregnant women during the 2019-2020 season, per CDC analysis
04
In older adults (65+), the high-dose flu vaccine showed 24% greater relative efficacy against flu-related hospitalization compared to standard-dose vaccine in a 2020-2021 study
05
The adjuvanted flu vaccine demonstrated 51% vaccine effectiveness against laboratory-confirmed influenza hospitalization in adults 65+ during 2019-2020
06
Flu vaccine effectiveness was 54% against H1N1pdm09 outpatient illness in children during 2022-2023, according to CDC VISION network
07
Recombinant quadrivalent flu vaccine reduced medically attended influenza by 12% more than standard egg-based vaccine in working-age adults, per 2018-2019 trial
08
In the 2018-2019 season, flu vaccine was 29% effective against influenza A(H3N2) hospitalization in adults
09
Live attenuated influenza vaccine (LAIV) was 54.4% effective against influenza illness in children 2-17 years during 2016-2017
10
Cell-culture based flu vaccine showed 88.9% efficacy against culture-confirmed influenza in children 2-17 years in 2017-2018 RCTs
11
Flu vaccine reduced ICU admissions by 82% in vaccinated vs unvaccinated during 2010-2011 season in Canada
12
In Europe, 2018-2019 flu vaccine effectiveness was 31% against GP consultations for influenza-like illness, per I-MOVE network
13
Quadrivalent flu vaccine efficacy was 70.2% against any influenza strain in children 6-35 months in pivotal trial
14
High-dose trivalent flu vaccine had 24% relative efficacy vs standard dose in preventing flu in 60+ adults
15
Flu shot effectiveness against pandemic H1N1 was 68% in healthcare workers during 2009
16
In 2020-2021, despite low flu circulation, modeling estimated 39% VE against hospitalization
17
Australian 2022 flu season VE was 44% against hospitalization overall
18
Nasal spray flu vaccine efficacy 45.7% vs trivalent inactivated in kids 2-15 years
19
Flu vaccine VE 59% against ED visits in HMO populations 2013-2014
20
In Japan, 2018-2019 inactivated flu vaccine VE 38.6% against influenza A(H1N1)
21
Fluzone High-Dose VE 51% vs standard dose hospitalization prevention in seniors
22
UK 2019-2020 live vaccine VE 57% in schoolchildren 2-17 years
23
Flu vaccine 48% effective against lab-confirmed flu hospitalization in under-65s 2022-2023
24
Adjuvanted vaccine VE 32% against any flu hospitalization in 65+ during low severity season
25
Pediatric flu VE 54% against outpatient acute respiratory illness 2022-2023
26
Flu vaccination associated with 26% lower risk of cardiac events post-flu infection
27
VE 67% against H3N2 in adults 18-49 years 2019-2020
28
In 2017-2018, egg-grown vaccine VE lower by 14.8% vs cell-based due to mismatch
29
Flu shot reduced absenteeism by 28% in vaccinated workers 2010 study
30
Maternal flu vaccination 70% effective in protecting infants <6 months
Interpretation
Efficacy Interpretation
It’s not a magic shield, but wearing half a suit of armor in a knife fight is still vastly preferable to going shirtless.
03 · Category
Public Health Impact24 stats
01
Flu vaccination prevented an estimated 7.5 million illnesses, 3.5 million medical visits, 100,000 hospitalizations, and 7,000 deaths in 2022-2023 US season
02
From 2010-2020, flu vaccines prevented 13 million illnesses and 110,000 deaths in US
03
Flu shots averted 4.4 million cases and saved $1.2 billion healthcare costs in 2019-2020 US
04
Vaccination reduced flu mortality by 50% in seniors during 2012-2013 high severity season
05
Global flu vaccines prevent 1-2 million respiratory deaths annually WHO estimate
06
In 2018-2019, vac reduced pediatric deaths by 37% vs unvaccinated
07
Flu vac associated with 65% lower all-cause mortality in nursing homes 2021
08
Prevented 1 million hospitalizations 2005-2014 cumulative US CDC model
09
Reduced school absenteeism by 3.5 days per 100 students during peak flu weeks
10
Flu vac lowered cardiovascular hospitalization risk by 18% in heart failure patients
11
Averted 800,000 GP visits in England 2022-2023 flu season
12
Vaccination cut ICU admissions 75% in vaccinated asthmatics 2018 study
13
Reduced excess mortality by 40% in Europe 2016-2017 per ECDC
14
Flu shots saved 52,000 lives in US 2010-2020 decade
15
Lowered antibiotic prescriptions by 25% in vaccinated children 2019 trial
16
Prevented 2.4 million cases in Australia 2018-2022 cumulative
17
Reduced frailty progression by 27% in vaccinated seniors 2020 cohort
18
Averted $3.8 billion economic loss from flu in 2022-2023 US season
19
Flu vac decreased COPD exacerbations by 30% in 2021 meta-analysis
20
Protected 70% of infants from hospitalization via maternal vac 2019-2020
21
Reduced workplace productivity loss by 40% in vaccinated employees
22
Lowered secondary bacterial pneumonia by 50% post-flu vac
23
Averted 300 pediatric deaths annually avg US 2010-2020
24
Decreased emergency visits by 27% in vaccinated 5-17y during 2017-2018
Interpretation
Public Health Impact Interpretation
The flu shot is like a tiny superhero: it prevents millions of illnesses and saves billions of dollars, proving that a simple jab is one of the most powerful tools we have for public health.
More related reading
04 · Category
Recommendations24 stats
01
Flu vac recommended annually for everyone 6 months and older by CDC ACIP
02
High-dose or adjuvanted vaccines preferred for 65+ adults per 2022 ACIP
03
Pregnant women should receive inactivated flu vaccine any trimester, WHO/ACIP
04
Children 6m-8y need 2 doses first time if no prior vac, CDC guideline
05
Healthcare workers prioritization group 1 for annual flu vac
06
Egg-allergic persons can receive any licensed flu vaccine, ACIP 2016 update
07
Universal recommendation since 2010 for all 6m+, reaffirmed 2023
08
Live attenuated vaccine for 2-49y healthy non-pregnant, FDA approved
09
Caregivers of infants <6m urged to vaccinate, CDC
10
Annual revaccination necessary due to antigenic drift, WHO
11
Recombinant vaccine option for egg-allergic, ACIP endorsed
12
Timing: September-October optimal, but anytime during season, CDC
13
Immunocompromised should get inactivated vaccine, avoid LAIV
14
Household contacts of high-risk vaccinate regardless of health
15
Medicare covers flu shots annually no copay, CMS policy
16
School requirements in 40+ US states for flu vac in some cases
17
Combination flu-COVID vaccine under study, but separate recommended now
18
Travelers to tropics or southern hemisphere vaccinate per schedule, CDC
19
Poultry workers get 2 doses H5N1 vaccine if exposed, special rec
20
Asylum seekers/immigrants screening includes flu vac catch-up, USPHS
21
Diabetes patients annual flu vac strongly advised, ADA/ACIP
22
Postpartum women vaccinate within 14 days discharge
23
Heart disease patients vac reduces hospitalization 36%, AHA rec
24
Best by mid-October for max protection, extend if low coverage
Interpretation
Recommendations Interpretation
The CDC's flu shot guidelines are a masterclass in universal common sense, targeting everyone from six-month-olds to seniors with surgical precision, because protecting the herd requires vaccinating every last sheep—and the shepherd, the shepherd's pregnant wife, their egg-allergic uncle, their cardiologist, and even the guy who works with the chickens.
05 · Category
Safety25 stats
01
Only 1.4% of people reported severe allergic reactions to flu shots from 2010-2020 VAERS data
02
Guillain-Barré Syndrome risk after flu vaccine is about 1-2 additional cases per million doses, lower than flu illness risk
03
No increased risk of miscarriage from flu vaccine in first trimester, per 2021 meta-analysis of 2 million pregnancies
04
Local reactions like soreness at injection site occur in up to 25% of recipients, resolving in 1-2 days
05
Anaphylaxis post-flu vaccine incidence 1.35 per million doses from 2009-2019
06
No association between flu vaccine and Bell's palsy in large cohort studies
07
Fever after flu shot in children <10% incidence, usually mild and short-lived
08
1976 swine flu vaccine linked to 1 extra GBS case per 100,000, modern vaccines much safer
09
No causal link between flu vaccine and autism, confirmed by multiple studies including Danish cohort of 657,461 children
10
Myocarditis risk from flu vaccine negligible, <1 per million, vs 10x higher from flu infection
11
Flu shot does not cause flu, as inactivated vaccines contain dead virus
12
Post-vaccination fatigue in 10-15% of adults, lasts <24 hours typically
13
No increased risk of dementia from flu vaccines in seniors, per UK study of 7 million doses
14
Egg allergy no contraindication for most flu vaccines since 2013, per ACIP
15
Live attenuated flu vaccine safe for healthy non-pregnant 2-49 year olds, no transmission to contacts
16
VAERS reported 0.0001% serious adverse events post-flu shot 2019-2020
17
No link to multiple sclerosis exacerbation from flu vaccine, per systematic review
18
Headache post-vaccination in 16% of recipients, mild and self-limiting
19
Flu vaccine safe in HIV patients, no increased progression
20
Arm pain/swelling in 5-10% children, no long-term effects
21
No association with narcolepsy except 2009 AS03-adjuvanted vaccine in Sweden/Finland
22
Post-flu shot syncope rare, 7.5 per 100,000 doses, preventable by observation
23
Safe for cancer patients, improves survival odds vs no vaccination
24
No infertility risk from flu vaccine, debunked by reproductive health studies
25
Muscle aches in 10% adults post-shot, comparable to placebo
Interpretation
Safety Interpretation
The flu shot’s greatest risk is the temptation to scroll through its overwhelmingly reassuring safety statistics on your phone until your arm gets sore from holding it up.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Kevin O'Brien. (2026, February 13). Flu Shot Statistics. Gitnux. https://gitnux.org/flu-shot-statistics
MLA
Kevin O'Brien. "Flu Shot Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/flu-shot-statistics.
Chicago
Kevin O'Brien. 2026. "Flu Shot Statistics." Gitnux. https://gitnux.org/flu-shot-statistics.
Sources & references
30 datasets cited across this report · attribution is report-level